Hansen Medical Inc (HNSN) 3.99 $HNSN
HANSEN MEDICAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Hansen Medical, Inc. (HNSN) Over the Proposed Sale of the Company to Auris Surgical Robotics, Inc.
BusinessWire - Wed Apr 27, 3:35PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Hansen Medical, Inc. ("Hansen Medical" or the "Company"
(NASDAQ:HNSN) for potential breaches of fiduciary duties in connection with the sale of the Company to Auris Surgical Robotics, Inc. for approximately $80 million in an all-cash transaction.
HNSN: 3.99 (unch)
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Hansen Medical, Inc. and Encourages Shareholders to Contact the Firm for Additional Information
BusinessWire - Tue Apr 26, 2:20PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Hansen Medical Inc. (Hansen or the "Company" (Nasdaq: HNSN) relating to the proposed buyout of the Company by Auris Surgical Robotics, Inc.
HNSN: 3.99 (unch)
Hansen Medical(R) Announces Filing of 510K for Expanded Neurological Indication for Magellan(TM) Product Line
Marketwired - Tue Apr 26, 7:00AM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today provides an update on the status of its key corporate initiative to expand the utility and regulatory labeling of the Magellan(TM) product line.
HNSN: 3.99 (unch)
Hansen Medical(R) to Highlight Benefits and Future of Magellan(TM) Robotic System Technology and Present Magellan Robotic System at Charing Cross International Symposium
Marketwired - Mon Apr 25, 7:02AM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the Charing Cross International Symposium in London, United Kingdom from April 26th to April 29th.
HNSN: 3.99 (unch)
Ryan & Maniskas, LLP Announces Investigation of Hansen Medical, Inc.
PR Newswire - Fri Apr 22, 10:19AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Hansen Medical, Inc. ("Hansen Medical" or the "Company" (NASDAQ: HNSN) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Auris Surgical Robotics, Inc. in a transaction valued at approximately $80 million.
HNSN: 3.99 (unch)
Harwood Feffer LLP Announces Investigation of Hansen Medical, Inc.
PR Newswire - Thu Apr 21, 4:20PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Hansen Medical, Inc. ("Hansen" or the "Company" (NASDAQ: HNSN) concerning the proposed acquisition of the Company by Auris Surgical Robotics, Inc. ("Auris" .
HNSN: 3.99 (unch)
Hansen Medical, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Auris Surgical Robotics, Inc.
BusinessWire - Thu Apr 21, 1:24PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Hansen Medical, Inc. ("Hansen" (NASDAQ: HNSN) concerning the merger with Auris Surgical Robotics, Inc. Under the terms of the agreement, valued at approximately $80 million, Hansen shareholders will only receive $4.00 per share held.
HNSN: 3.99 (unch)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Hansen Medical, Inc. -HNSN
PR Newswire - Wed Apr 20, 9:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Hansen Medical, Inc. ("Hansen Medical" or "the Company" (Nasdaq- HNSN-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Auris Surgical Robotics, Inc. ("Auris" .
HNSN: 3.99 (unch)
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Hansen Medical, Inc. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Wed Apr 20, 9:20PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Hansen Medical Inc. (Hansen or the "Company" (Nasdaq: HNSN) relating to the proposed buyout of the Company by Auris Surgical Robotics, Inc.
HNSN: 3.99 (unch)
HANSEN MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Wed Apr 20, 10:29AM CDT
Rigrodsky & Long, P.A.:
HNSN: 3.99 (unch)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of Hansen Medical, Inc. for $4.00 Per Share to Auris Surgical Robotics, Inc. is Fair to Shareholders
ACCESSWIRE - Wed Apr 20, 9:21AM CDT
NEW YORK, NY / ACCESSWIRE / April 20, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
HNSN: 3.99 (unch)
HANSEN (HNSN) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Hansen Medical, Inc.; Are Hansen Shareholders Getting a Fair Price?
PR Newswire - Wed Apr 20, 8:34AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Hansen Medical, Inc. (NASDAQ: HNSN) breached their fiduciary duties in connection with the proposed sale of the Company to Auris Surgical Robotics, Inc.
HNSN: 3.99 (unch)
HANSEN BUYOUT ALERT - National Securities Law Firm Seeks Higher Price for Hansen Medical Shareholders in Connection with Proposed Buyout, and Encourages Shareholders to Contact Law Firm for More Information
PR Newswire - Wed Apr 20, 7:40AM CDT
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the potential sale of Hansen Medical, Inc. (NASDAQ: HNSN) ("Hansen" or the "Company" on behalf of its shareholders. Hansen announced that it has entered into a definitive agreement to be acquired by Auris Surgical Robotics, Inc. for $4 per share. In addition, certain significant shareholders of Hansen have agreed to invest approximately $49 million into Auris contemporaneously with the closing of the transaction.
HNSN: 3.99 (unch)
Auris Surgical Robotics Agrees to Acquire Hansen Medical
Marketwired - Wed Apr 20, 7:01AM CDT
Auris Surgical Robotics, Inc. and Hansen Medical, Inc. (NASDAQ: HNSN) today announced that they have signed a definitive merger agreement under which Auris will acquire Hansen Medical for $4.00 per share in cash, or a total equity value of approximately $80 million. The purchase price per share represents a premium of approximately 39.9% over the closing sale price of common stock of Hansen Medical as reported on NASDAQ on April 19, 2016. In addition, certain significant stockholders of Hansen Medical have agreed to invest approximately $49 million into Auris contemporaneously with the closing of the transaction.
HNSN: 3.99 (unch)
Hansen Medical(R), Inc. Receives NASDAQ Letter Regarding Late Form 10-K Filing
Marketwired - Wed Apr 06, 4:00PM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN) today announced that it received a notification letter on March 31, 2016 from The NASDAQ Stock Market ("NASDAQ" . The notification letter stated that because the Company has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2015 (the "Form 10-K" , the Company is no longer in compliance with NASDAQ Marketplace Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (the "SEC" .
HNSN: 3.99 (unch)
Hansen Medical(R) to Demonstrate New Magellan(TM) Robotic Catheter eKit and Present Magellan Robotic System at 41st Annual Society of Interventional Radiology (SIR) Scientific Meeting
Marketwired - Thu Mar 17, 7:00AM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the Annual Society of Interventional Radiology (SIR) Scientific Meeting April 2-7 in Vancouver, British Columbia, Canada. The Company will showcase the newly approved Magellan Robotic Catheter eKit that has been used by Interventional Radiologists in a variety of procedures, including Uterine Fibroid Embolization (UFE), Bilateral Renal Embolization, and Radioembolization. The Magellan Robotic System and the family of Magellan Robotic Catheters will be demonstrated at exhibit booth # 1038.
HNSN: 3.99 (unch)
4 Stocks That are Making Big Moves Early Today
ACCESSWIRE - Tue Feb 02, 9:23AM CST
NEW YORK, NY / ACCESSWIRE / February 2, 2016 / The Stock Expert is issuing a report on four stocks to watch. HDP, EYEG, LOJN and HNSN have been attracting the attention of major investors today. Continue reading to find out why. - To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
HDP: 12.39 (+0.68), HNSN: 3.99 (unch), LOJN: 6.44 (-0.01), EYEG: 2.09 (+0.07)
Hansen Medical(R) Announces Latest Publication in the Journal of Interventional Cardiac Electrophysiology
Marketwired - Mon Feb 01, 7:00AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the latest publication in the Journal of Cardiac Electrophysiology: Analysis of catheter contact force during atrial fibrillation ablation, using the robotic navigation system: results from a randomized study.
HNSN: 3.99 (unch)
BUYINS.NET Issues Hansen Medical (HNSN) SqueezeTrigger Report
M2 - Wed Jan 27, 6:52AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Hansen Medical, Inc. (NASDAQ: HNSN) after releasing the latest short sale data through January 26, 2016. The total aggregate number of shares shorted since August 2009 is approximately 24.35 million shares. Approximately 29.31% of daily trading volume is short selling. The SqueezeTrigger price for all HNSN shares shorted is $23.67. Approximately 459,000 total shares have been shorted below $3.00 and are expected to squeeze when the stock exceeds this level.
HNSN: 3.99 (unch)
The Life Sciences Report Interviews Alan Leong of BioWatch News
Marketwired - Fri Jan 22, 8:00AM CST
Combining academic discipline with methodical due diligence, Alan Leong of BioWatch News undertakes a regimented review of each biotech and medtech stock he investigates. In some cases he will follow a company's clinical development program and data for years before he pulls the trigger and recommends a name. In this interview with The Life Sciences Report, Leong presents a number of names for investors' consideration. Many won't be mentioned in his usual write-ups: It's an early look at what's on his watch list and in his inbox. Each company carries its own risks, but every stock has a special growth story that could propel huge gains if data fall into place.
CPH.TO: 6.58 (+0.03), RVX.TO: 1.19 (-0.01), HNSN: 3.99 (unch), CPHR: 4.96 (-0.04)
HANSEN MEDICAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Hansen Medical, Inc. (HNSN) Over the Proposed Sale of the Company to Auris Surgical Robotics, Inc.
BusinessWire - Wed Apr 27, 3:35PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Hansen Medical, Inc. ("Hansen Medical" or the "Company"
(NASDAQ:HNSN) for potential breaches of fiduciary duties in connection with the sale of the Company to Auris Surgical Robotics, Inc. for approximately $80 million in an all-cash transaction. HNSN: 3.99 (unch)
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Hansen Medical, Inc. and Encourages Shareholders to Contact the Firm for Additional Information
BusinessWire - Tue Apr 26, 2:20PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Hansen Medical Inc. (Hansen or the "Company"
(Nasdaq: HNSN) relating to the proposed buyout of the Company by Auris Surgical Robotics, Inc. HNSN: 3.99 (unch)
Hansen Medical(R) Announces Filing of 510K for Expanded Neurological Indication for Magellan(TM) Product Line
Marketwired - Tue Apr 26, 7:00AM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today provides an update on the status of its key corporate initiative to expand the utility and regulatory labeling of the Magellan(TM) product line.
HNSN: 3.99 (unch)
Hansen Medical(R) to Highlight Benefits and Future of Magellan(TM) Robotic System Technology and Present Magellan Robotic System at Charing Cross International Symposium
Marketwired - Mon Apr 25, 7:02AM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the Charing Cross International Symposium in London, United Kingdom from April 26th to April 29th.
HNSN: 3.99 (unch)
Ryan & Maniskas, LLP Announces Investigation of Hansen Medical, Inc.
PR Newswire - Fri Apr 22, 10:19AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Hansen Medical, Inc. ("Hansen Medical" or the "Company"
(NASDAQ: HNSN) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Auris Surgical Robotics, Inc. in a transaction valued at approximately $80 million. HNSN: 3.99 (unch)
Harwood Feffer LLP Announces Investigation of Hansen Medical, Inc.
PR Newswire - Thu Apr 21, 4:20PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Hansen Medical, Inc. ("Hansen" or the "Company"
(NASDAQ: HNSN) concerning the proposed acquisition of the Company by Auris Surgical Robotics, Inc. ("Auris" . HNSN: 3.99 (unch)
Hansen Medical, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Auris Surgical Robotics, Inc.
BusinessWire - Thu Apr 21, 1:24PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Hansen Medical, Inc. ("Hansen"
(NASDAQ: HNSN) concerning the merger with Auris Surgical Robotics, Inc. Under the terms of the agreement, valued at approximately $80 million, Hansen shareholders will only receive $4.00 per share held. HNSN: 3.99 (unch)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Hansen Medical, Inc. -HNSN
PR Newswire - Wed Apr 20, 9:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Hansen Medical, Inc. ("Hansen Medical" or "the Company"
(Nasdaq- HNSN-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Auris Surgical Robotics, Inc. ("Auris" . HNSN: 3.99 (unch)
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Hansen Medical, Inc. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Wed Apr 20, 9:20PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Hansen Medical Inc. (Hansen or the "Company"
(Nasdaq: HNSN) relating to the proposed buyout of the Company by Auris Surgical Robotics, Inc. HNSN: 3.99 (unch)
HANSEN MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Wed Apr 20, 10:29AM CDT
Rigrodsky & Long, P.A.:
HNSN: 3.99 (unch)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of Hansen Medical, Inc. for $4.00 Per Share to Auris Surgical Robotics, Inc. is Fair to Shareholders
ACCESSWIRE - Wed Apr 20, 9:21AM CDT
NEW YORK, NY / ACCESSWIRE / April 20, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
HNSN: 3.99 (unch)
HANSEN (HNSN) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Hansen Medical, Inc.; Are Hansen Shareholders Getting a Fair Price?
PR Newswire - Wed Apr 20, 8:34AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Hansen Medical, Inc. (NASDAQ: HNSN) breached their fiduciary duties in connection with the proposed sale of the Company to Auris Surgical Robotics, Inc.
HNSN: 3.99 (unch)
HANSEN BUYOUT ALERT - National Securities Law Firm Seeks Higher Price for Hansen Medical Shareholders in Connection with Proposed Buyout, and Encourages Shareholders to Contact Law Firm for More Information
PR Newswire - Wed Apr 20, 7:40AM CDT
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the potential sale of Hansen Medical, Inc. (NASDAQ: HNSN) ("Hansen" or the "Company"
on behalf of its shareholders. Hansen announced that it has entered into a definitive agreement to be acquired by Auris Surgical Robotics, Inc. for $4 per share. In addition, certain significant shareholders of Hansen have agreed to invest approximately $49 million into Auris contemporaneously with the closing of the transaction. HNSN: 3.99 (unch)
Auris Surgical Robotics Agrees to Acquire Hansen Medical
Marketwired - Wed Apr 20, 7:01AM CDT
Auris Surgical Robotics, Inc. and Hansen Medical, Inc. (NASDAQ: HNSN) today announced that they have signed a definitive merger agreement under which Auris will acquire Hansen Medical for $4.00 per share in cash, or a total equity value of approximately $80 million. The purchase price per share represents a premium of approximately 39.9% over the closing sale price of common stock of Hansen Medical as reported on NASDAQ on April 19, 2016. In addition, certain significant stockholders of Hansen Medical have agreed to invest approximately $49 million into Auris contemporaneously with the closing of the transaction.
HNSN: 3.99 (unch)
Hansen Medical(R), Inc. Receives NASDAQ Letter Regarding Late Form 10-K Filing
Marketwired - Wed Apr 06, 4:00PM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN) today announced that it received a notification letter on March 31, 2016 from The NASDAQ Stock Market ("NASDAQ"
. The notification letter stated that because the Company has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2015 (the "Form 10-K" , the Company is no longer in compliance with NASDAQ Marketplace Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (the "SEC" . HNSN: 3.99 (unch)
Hansen Medical(R) to Demonstrate New Magellan(TM) Robotic Catheter eKit and Present Magellan Robotic System at 41st Annual Society of Interventional Radiology (SIR) Scientific Meeting
Marketwired - Thu Mar 17, 7:00AM CDT
Hansen Medical(R), Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan(TM) Robotic System at the Annual Society of Interventional Radiology (SIR) Scientific Meeting April 2-7 in Vancouver, British Columbia, Canada. The Company will showcase the newly approved Magellan Robotic Catheter eKit that has been used by Interventional Radiologists in a variety of procedures, including Uterine Fibroid Embolization (UFE), Bilateral Renal Embolization, and Radioembolization. The Magellan Robotic System and the family of Magellan Robotic Catheters will be demonstrated at exhibit booth # 1038.
HNSN: 3.99 (unch)
4 Stocks That are Making Big Moves Early Today
ACCESSWIRE - Tue Feb 02, 9:23AM CST
NEW YORK, NY / ACCESSWIRE / February 2, 2016 / The Stock Expert is issuing a report on four stocks to watch. HDP, EYEG, LOJN and HNSN have been attracting the attention of major investors today. Continue reading to find out why. - To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
HDP: 12.39 (+0.68), HNSN: 3.99 (unch), LOJN: 6.44 (-0.01), EYEG: 2.09 (+0.07)
Hansen Medical(R) Announces Latest Publication in the Journal of Interventional Cardiac Electrophysiology
Marketwired - Mon Feb 01, 7:00AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the latest publication in the Journal of Cardiac Electrophysiology: Analysis of catheter contact force during atrial fibrillation ablation, using the robotic navigation system: results from a randomized study.
HNSN: 3.99 (unch)
BUYINS.NET Issues Hansen Medical (HNSN) SqueezeTrigger Report
M2 - Wed Jan 27, 6:52AM CST
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Hansen Medical, Inc. (NASDAQ: HNSN) after releasing the latest short sale data through January 26, 2016. The total aggregate number of shares shorted since August 2009 is approximately 24.35 million shares. Approximately 29.31% of daily trading volume is short selling. The SqueezeTrigger price for all HNSN shares shorted is $23.67. Approximately 459,000 total shares have been shorted below $3.00 and are expected to squeeze when the stock exceeds this level.
HNSN: 3.99 (unch)
The Life Sciences Report Interviews Alan Leong of BioWatch News
Marketwired - Fri Jan 22, 8:00AM CST
Combining academic discipline with methodical due diligence, Alan Leong of BioWatch News undertakes a regimented review of each biotech and medtech stock he investigates. In some cases he will follow a company's clinical development program and data for years before he pulls the trigger and recommends a name. In this interview with The Life Sciences Report, Leong presents a number of names for investors' consideration. Many won't be mentioned in his usual write-ups: It's an early look at what's on his watch list and in his inbox. Each company carries its own risks, but every stock has a special growth story that could propel huge gains if data fall into place.
CPH.TO: 6.58 (+0.03), RVX.TO: 1.19 (-0.01), HNSN: 3.99 (unch), CPHR: 4.96 (-0.04)
